Beta-Blocker Therapy Induces Ventricular Resynchronization in Dilated Cardiomyopathy With Narrow QRS Complex

Journal of the American College of Cardiology

Volumn 49, Issue 7, 2007, Pages 778-783

  Takemoto, Yasuhiko ^a   Hozumi, Takeshi ^a   Sugioka, Kenichi ^a   Takagi, Yasuhiro ^a   Matsumura, Yoshiki ^a   Yoshiyama, Minoru ^a   Abraham, Theodore P ^b   Yoshikawa, Junichi ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Osaka Ekisaikai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; PRIORITY JOURNAL; QRS COMPLEX;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; CARBAZOLES; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; REFERENCE VALUES; VENTRICULAR FUNCTION;

EID: 33846997219     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.081     Document Type: Article

References (30)

1. Ghio S., Constantin C., Klersy C., et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 25 (2004) 571-578
2. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
3. Yu C.M., Chau E., Sanderson J.E., et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105 (2002) 438-445
4. St. John Sutton M.G., Plappert T., Abraham W.T., et al. Effects of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
5. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
6. Gorcsan III J., Kanzaki H., Bazaz R., et al. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1178-1181
7. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STImulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2003) 111-118
8. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
9. Yu C.M., Lin H., and Zhang Q. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89 (2003) 54-60
10. Abraham T.P., Nishimura R.A., Holmes D.R., et al. Strain rate imaging for assessment of regional myocardial function. Circulation 105 (2002) 1403-1406
11. Packer M., Colucci W.S., Sackner-Bernstein J.D., et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial. Circulation 94 (1996) 2793-2799
12. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94 (1996) 2807-2816
13. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
14. Packer M., Fowler M.B., Roecker E.B., et al. Effects of carvedilol on the mortality of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 (2002) 2194-2199
15. Poole-Wilson P.A., Swedberg K., Cleland J.G., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial. Lancet 362 (2003) 7-13
16. Bristow M.R., Roden R.L., Lowes B.D., et al. The role of third generation β-blocking agents in chronic heart failure. Clin Cardiol 21 (1998) I-3-I-13
17. Mann D.L., Kent R.L., Parsons B., et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 (1992) 790-804
18. Communal C., Singh K., Pimental D.R., et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic receptor. Circulation 98 (1998) 1329-1334
19. Garcia-Fernandez M.A., Azevedo J., Moreno M., et al. Regional diastolic function in ischemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J 20 (1999) 496-505
20. Heimdal A., Stoylen A., Trop H., et al. Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr 11 (1998) 1013-1019
21. Miyatake K., Yamagishi M., Tanaka N., et al. New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: in vitro and in vivo studies. J Am Coll Cardiol 25 (1995) 717-724
22. Urheim S., Edvardsen T., Torp H., et al. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
23. Edvardsen T., Gerber B.L., Garot J., et al. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 106 (2002) 50-56
24. Tsutsui H., Spinale F.G., Nagatsu M., et al. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 93 (1994) 2639-2648
25. Plank D.M., Yatani A., Ritsu H., et al. Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 285 (2003) H305-H315
26. Reiken S., Wehrens X.H., Vest J.A., et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
27. Yano M., Kobayashi S., Kohno M., et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107 (2003) 477-484
28. Sugioka K., Hozumi T., Takemoto Y., et al. Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study. J Am Coll Cardiol 45 (2005) 318-319
29. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102 (2000) 3053-3059
30. Sundell J., Engblom E., Koistinen J., et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 43 (2004) 1027-1033